Amneal Pharmaceuticals, Inc. (FRA:2DT)
10.90
0.00 (0.00%)
Last updated: Jan 9, 2026, 3:29 PM CET
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of €3.5 billion as of January 12, 2026. Its market cap has increased by 50.88% in one year.
Market Cap
3.50B
Enterprise Value
5.69B
Revenue
2.50B
Ranking
n/a
PE Ratio
696.53
Stock Price
€10.90
Market Cap Chart
Since May 7, 2018, Amneal Pharmaceuticals's market cap has increased from 1.60B to 3.50B, an increase of 119.01%. That is a compound annual growth rate of 10.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 3.50B | 3.82% |
| Dec 31, 2025 | 3.37B | 42.33% |
| Dec 31, 2024 | 2.37B | 40.80% |
| Dec 29, 2023 | 1.68B | 496.83% |
| Dec 30, 2022 | 282.05M | -55.17% |
| Dec 31, 2021 | 629.13M | 14.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |